Management of relapsed or refractory Hodgkin lymphoma with second-generation antibody-drug conjugates: focus on brentuximab vedotin

por Mei, Matthew, Thomas, Sandra, Chen, Robert
Publicado em 2014

Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia

por Aldoss, Ibrahim, Zhang, Jianying, Pillai, Raju, Shouse, Geoff, Sanchez, James F, Mei, Matthew, Nakamura, Ryotaro, Stein, Anthony S, Forman, Stephen J, Marcucci, Guido, Pullarkat, Vinod
Publicado no Br J Haematol (2019)

Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma

por Krishnan, Amrita Y., Mei, Matthew, Sun, Can-Lan, Thomas, Sandra H., Berano Teh, Jennifer, Kang, Tongjun, Htut, Myo, Somlo, George, Sahebi, Firoozeh, Forman, Stephen J., Bhatia, Smita
Publicado em 2012

Outcomes of patients with recurrent and refractory lymphoma undergoing allogeneic hematopoietic cell transplantation with BEAM conditioning and sirolimus and tacrolimus based GVHD...

por Salhotra, Amandeep, Mei, Matthew, Stiller, Tracey, Mokhtari, Sally, Herrera, Alex F., Chen, Robert, Popplewell, Leslie, Zain, Jasmine, Ali, Haris, Sandhu, Karamjeet, Budde, Elizabeth, Nademanee, Auayporn, Forman, Stephen J., Nakamura, Ryotaro
Publicado no Biol Blood Marrow Transplant (2018)

Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

por Aldoss, Ibrahim, Yang, Dongyun, Aribi, Ahmed, Ali, Haris, Sandhu, Karamjeet, Al Malki, Monzr M., Mei, Matthew, Salhotra, Amandeep, Khaled, Samer, Nakamura, Ryotaro, Snyder, David, O’Donnell, Margaret, Stein, Anthony S., Forman, Stephen J., Marcucci, Guido, Pullarkat, Vinod
Publicado no Haematologica (2018)

Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma

por Mohanty, Atish, Sandoval, Natalie, Phan, An, Nguyen, Thang V., Chen, Robert W., Budde, Elizabeth, Mei, Matthew, Popplewell, Leslie, Pham, Lan V., Kwak, Larry W., Weisenburger, Dennis D., Rosen, Steven T., Chan, Wing C., Müschen, Markus, Ngo, Vu N.
Publicado no Blood (2019)

Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents

por Aldoss, Ibrahim, Dadwal, Sanjeet, Zhang, Jianying, Tegtmeier, Bernard, Mei, Matthew, Arslan, Shukaib, Al Malki, Monzr M., Salhotra, Amandeep, Ali, Haris, Aribi, Ahmed, Sandhu, Karamjeet, Khaled, Samer, Snyder, David, Nakamura, Ryotaro, Stein, Anthony S., Forman, Stephen J., Marcucci, Guido, Pullarkat, Vinod
Publicado no Blood Adv (2019)

Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell Transplantation

por Slavin, Thomas P., Teh, Jennifer Berano, Weitzel, Jeffrey N., Peng, Kelly, Wong, F. Lennie, Qin, Hanjun, Wang, Jinhui, Wu, Xiewei, Mei, Matthew, Pillai, Raju, Wang, Yafan, Tsang, Kevin Karwing, Pozhitkov, Alex, Krishnan, Amrita, Forman, Stephen J., Armenian, Saro H.
Publicado no Biol Blood Marrow Transplant (2019)

Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes

por Aldoss, Ibrahim, Pillai, Raju, Yang, Dongyun, Yang, Lixin, Arslan, Shukaib, Mokhtari, Sally, Malki, Monzr M. Al, Salhotra, Amandeep, Shahani, Shilpa, Ali, Haris, Mei, Matthew, Artz, Andrew, Snyder, David, Afkhami, Michelle, Armenian, Saro, Stein, Anthony, Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Pullarkat, Vinod
Publicado no Blood Cancer J (2021)

MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

por Ali, Haris, Aldoss, Ibrahim, Yang, Dongyun, Mokhtari, Sally, Khaled, Samer, Aribi, Ahmed, Afkhami, Michelle, Al Malki, Monzr M., Cao, Thai, Mei, Matthew, O’Donnell, Margaret, Salhotra, Amandeep, Pullarkat, Vinod, Yang, Lixin, Stein, Anthony S., Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Pillai, Raju, Snyder, David
Publicado no Blood Adv (2019)

Melphalan-based reduced intensity conditioning is associated with favorable disease control and acceptable toxicities in patients older than 70 with hematologic malignancies underg...

por Al Malki, Monzr M., Nathwani, Nitya, Yang, Dongyun, Armenian, Saro, Dadwal, Sanjeet, Salman, Jaroslava, Mokhtari, Sally, Cao, Thai, Sandhu, Karamjeet, Rouse, Michelle, Mei, Matthew, Ali, Haris, Parker, Pablo, Alvarnas, Joseph, Smith, Eileen, Donnell, Margaret O, Marcucci, Guido, Snyder, David, Nademanee, Auayporn, Forman, Stephen J., Stein, Anthony, Nakamura, Ryotaro
Publicado no Biol Blood Marrow Transplant (2018)

Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transpl...

por Aldoss, Ibrahim, Stiller, Tracey, Tsai, Ni-Chun, Song, Joo Y., Cao, Thai, Bandara, N. Achini, Salhotra, Amandeep, Khaled, Samer, Aribi, Ahmed, Al Malki, Monzr M., Mei, Matthew, Ali, Haris, Spielberger, Ricardo, O’Donnell, Margaret, Snyder, David, Slavin, Thomas, Nakamura, Ryotaro, Stein, Anthony S., Forman, Stephen J., Marcucci, Guido, Pullarkat, Vinod
Publicado no Haematologica (2018)

Inhibition of MDR1 overcomes resistance to brentuximab vedotin in Hodgkin lymphoma

por Chen, Robert, Herrera, Alex F., Hou, Jessie, Chen, Lu, Wu, Jun, Guo, Yuming, Synold, Timothy W., Ngo, Vu N., Puverel, Sandrine, Mei, Matthew, Popplewell, Leslie, Yi, Shuhua, Song, Joo Y., Tao, Shu, Wu, Xiwei, Chan, Wing C, Forman, Stephen J., Kwak, Larry W., Rosen, Steven T., Newman, Edward M.
Publicado no Clin Cancer Res (2019)

Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab

por Mei, Matthew G., Cao, Thai M., Chen, Lu, Song, Joo, Siddiqi, Tanya, Cai, Ji-Lian, Farol, Leonardo T., Al Malki, Monzr M., Salhotra, Amandeep, Aldoss, Ibrahim, Palmer, Joycelynne, Herrera, Alex F., Zain, Jasmine, Popplewell, Leslie L., Chen, Robert W., Rosen, Steven T., Forman, Stephen J., Kwak, Larry, Nademanee, Auayporn P., Budde, Lihua E.
Publicado no Biol Blood Marrow Transplant (2017)

Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic hematopoietic cell transplantation in classical Hodgkin lymphoma.

por Ahmed, Sairah, Ghosh, Nilanjan, Ahn, Kwang Woo, Khanal, Manoj, Litovich, Carlos, Mussetti, Alberto, Chhabra, Saurabh, Cairo, Mitchell, Mei, Matthew, William, Basem, Nathan, Sunita, Bejanyan, Nelli, Olsson, Richard F., Dahi, Parastoo B., van der Poel, Marjolein, Steinberg, Amir, Kanakry, Jennifer, Cerny, Jan, Farooq, Umar, Seo, Sachiko, Kharfan-Dabaja, Mohamed A., Sureda, Anna, Fenske, Timothy S., Hamadani, Mehdi
Publicado no Br J Haematol (2020)

Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity

por Jacobson, Caron A., Hunter, Bradley D., Redd, Robert, Rodig, Scott J., Chen, Pei-Hsuan, Wright, Kyle, Lipschitz, Mikel, Ritz, Jerome, Kamihara, Yusuke, Armand, Philippe, Nikiforow, Sarah, Rogalski, Michael, Maakaron, Joseph, Jaglowski, Samantha, Maus, Marcela V., Chen, Yi-Bin, Abramson, Jeremy S., Kline, Justin, Budde, Elizabeth, Herrera, Alex, Mei, Matthew, Cohen, Jonathon B., Smith, Stephen D., Maloney, David G., Gopal, Ajay K., Frigault, Matthew J., Acharya, Utkarsh H.
Publicado no J Clin Oncol (2020)

Outcomes of rituximab-BEAM vs BEAM conditioning regimen in patients with diffuse large B-cell lymphoma undergoing autologous transplantation.

por Jagadeesh, Deepa, Majhail, Navneet S., He, Yizeng, Ahn, Kwang W., Litovich, Carlos, Ahmed, Sairah, Aljurf, Mahmoud, Bacher, Ulrike, Badawy, Sherif M., Bejanyan, Nelli, Cairo, Mitchell, Cerny, Jan, Epperla, Narendranath, Farhadfar, Nosha, Freytes, César O., Gale, Robert Peter, Haverkos, Bradley, Hossain, Nasheed, Inwards, David, Kamble, Rammurti T., Kenkre, Vaishalee P., Lazarus, Hillard M., Lazaryan, Aleksandr, Lekakis, Lazaros, Mei, Matthew, Murthy, Hemant S., Mussetti, Alberto, Nathan, Sunita, Nishihori, Taiga, Olsson, Richard F., Geethakumari, Praveen Ramakrishnan, Savani, Bipin N., Yared, Jean A., Fenske, Timothy S., Kharfan-Dabaja, Mohamed A., Sureda, Anna, Hamadani, Mehdi
Publicado no Cancer (2020)

Outcomes After Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma

por Herrera, Alex F., Rodig, Scott J., Song, Joo Y., Kim, Young, Griffin, Gabriel K., Yang, Dongyun, Nikolaenko, Liana, Mei, Matthew, Bedell, Victoria, Cin, Paola Dal, Pak, Christine, Alyea, Edwin P., Budde, Elizabeth, Chen, Robert, Chen, Yi-Bin, Chan, Wing C., Cutler, Corey S., Ho, Vincent T., Koreth, John, Krishnan, Amrita, Murata-Collins, Joyce L., Nikiforow, Sarah, Palmer, Joycelynne, Pihan, German A., Pillai, Raju, Popplewell, Leslie, Rosen, Steven T., Siddiqi, Tanya, Sohani, Aliyah R., Zain, Jasmine, Kwak, Larry W., Weisenburger, Dennis D., Weinstock, David M., Soiffer, Robert J., Antin, Joseph H., Forman, Stephen J., Nademanee, Auayporn P., Armand, Philippe
Publicado no Biol Blood Marrow Transplant (2017)

Autologous versus allogeneic transplantation in follicular lymphoma patients experiencing early treatment failure

por Smith, Sonali M., Godfrey, James, Ahn, Kwang Woo, DiGilio, Alyssa, Ahmed, Sairah, Agrawal, Vaibhav, Bachanova, Veronika, Bacher, Ulrike, Bashey, Asad, Bolaños-Meade, Javier, Cairo, Mitchell, Chen, Andy, Chhabra, Saurabh, Copelan, Edward, Dahi, Parastoo B., Aljurf, Mahmoud, Farooq, Umar, Ganguly, Siddhartha, Hertzberg, Mark, Holmberg, Leona, Inwards, David, Kanate, Abraham S., Karmali, Reem, Kenkre, Vaishalee P., Kharfan-Dabaja, Mohamed A., Klein, Andreas, Lazarus, Hillard M., Mei, Matthew, Mussetti, Alberto, Nishihori, Taiga, Geethakumari, Praveen Ramakrishnan, Saad, Ayman, Savani, Bipin N., Schouten, Harry C., Shah, Nairav, Urbano-Ispizua, Alvaro, Vij, Ravi, Vose, Julie, Sureda, Anna, Hamadani, Mehdi
Publicado no Cancer (2018)

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

por Herrera, Alex F., Mei, Matthew, Low, Lawrence, Kim, Haesook T., Griffin, Gabriel K., Song, Joo Y., Merryman, Reid W., Bedell, Victoria, Pak, Christine, Sun, Heather, Paris, Tanya, Stiller, Tracey, Brown, Jennifer R., Budde, Lihua E., Chan, Wing C., Chen, Robert, Davids, Matthew S., Freedman, Arnold S., Fisher, David C., Jacobsen, Eric D., Jacobson, Caron A., LaCasce, Ann S., Murata-Collins, Joyce, Nademanee, Auayporn P., Palmer, Joycelynne M., Pihan, German A., Pillai, Raju, Popplewell, Leslie, Siddiqi, Tanya, Sohani, Aliyah R., Zain, Jasmine, Rosen, Steven T., Kwak, Larry W., Weinstock, David M., Forman, Stephen J., Weisenburger, Dennis D., Kim, Young, Rodig, Scott J., Krishnan, Amrita, Armand, Philippe
Publicado no J Clin Oncol (2017)